Chairman Charles E. Grassley, right, and ranking member Sen. Ron Wyden are seen before a Senate Finance Committee on drug pricing in America on February 26, 2019. (Tom Williams/CQ Roll Call)
Both the House and the Senate have competing bills aimed at addressing the rising costs of prescription drugs, a legislative priority backed by President Donald Trump.
But what would these various proposals accomplish, and how likely is it they’ll be signed into law?
[jwp-video n=”1″]
Recent Stories
Tennessee Rep. Steve Cohen announces retirement after GOP dismantles his district
As RFK’s lifestyle seeps into policy, some fret over long-term effect
Wrapup: Busy week ends in Byrd bath
Louisiana Senate approves new map that would scrap majority-Black district
Photos of the week | May 5-14, 2026
Senate Banking approves crypto market structure bill